Invivyd (IVVD) Enterprise Value (QoQ) (2021 - 2025)
Invivyd (IVVD) Enterprise Value (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn |
| 10 | Invivyd | 104.02 Mn | -122.67 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -166.80% |
| Sep 30, 2025 | -143.42% |
| Jun 30, 2025 | 27.40% |
| Mar 31, 2025 | 30.67% |
| Dec 31, 2024 | 35.11% |
| Sep 30, 2024 | 27.73% |
| Jun 30, 2024 | 21.92% |
| Mar 31, 2024 | 5.61% |
| Dec 31, 2023 | -10.35% |
| Sep 30, 2023 | -49.10% |
| Jun 30, 2023 | 3.58% |
| Mar 31, 2023 | -37.36% |
| Dec 31, 2022 | 66.90% |
| Sep 30, 2022 | 41.43% |
| Jun 30, 2022 | 10.77% |
| Mar 31, 2022 | 1.84% |
| Dec 31, 2021 | -13.37% |
| Sep 30, 2021 | -21.85% |